Carfilzomib (2S,4R)-Diol
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Carfilzomib (2S,4R)-Diol Product Information
Carfilzomib (2S,4R)-Diol is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Carfilzomib. The product is supplied by Clearsynth under CAT No. CS-T-93647.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Carfilzomib (2S,4R)-Diol
CAT No.
CS-T-93647
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C40H59N5O8
Molecular Weight
737.9
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Carfilzomib (2S,4R)-Diol is supplied with detailed characterization data compliant with regulatory guideline. Carfilzomib (2S,4R)-Diol can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Carfilzomib.
Overview
Carfilzomib (2S,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
Synonyms
Carfilzomib (2S,4R)-Diol
Application Notes
Carfilzomib (2S,4R)-Diol is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.